<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(21)</volume><submitter>Mokhtari A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>European guidelines recommend the use of a 0h/1h hs-cTn (high-sensitivity cardiac troponin) protocol in patients with acute chest pain. We aimed to determine the performance of this protocol in routine care when supplemented with patient history and ECG and a recommendation to refrain from noninvasive testing in low-risk patients.&lt;h4>Methods and results&lt;/h4>This was a pre- and postimplementation study with concurrent controls. Patients with chest pain were enrolled at 5 Swedish emergency departments (EDs) during a 10-month period in both 2017 and 2018. All hospitals used a 0h/3h hs-cTnT protocol in 2017 and 3 EDs implemented a 0h/1h hs-cTnT protocol during 10 months in 2018. The 2 coprimary outcomes were the incidence of acute myocardial infarction and all-cause death wi</pubmed_abstract><journal>Journal of the American Heart Association</journal><pagination>e036307</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11935679</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effectiveness and Safety of the ESC-TROP (European Society of Cardiology 0h/1h Troponin Rule-Out Protocol) Trial.</pubmed_title><pmcid>PMC11935679</pmcid><pubmed_authors>Ellehuus C</pubmed_authors><pubmed_authors>Lindahl B</pubmed_authors><pubmed_authors>Mokhtari A</pubmed_authors><pubmed_authors>Bjork J</pubmed_authors><pubmed_authors>Sandgren J</pubmed_authors><pubmed_authors>Ekstrom U</pubmed_authors><pubmed_authors>Ekelund U</pubmed_authors><pubmed_authors>Hard Af Segerstad C</pubmed_authors><pubmed_authors>Khoshnood A</pubmed_authors><pubmed_authors>Forberg JL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effectiveness and Safety of the ESC-TROP (European Society of Cardiology 0h/1h Troponin Rule-Out Protocol) Trial.</name><description>&lt;h4>Background&lt;/h4>European guidelines recommend the use of a 0h/1h hs-cTn (high-sensitivity cardiac troponin) protocol in patients with acute chest pain. We aimed to determine the performance of this protocol in routine care when supplemented with patient history and ECG and a recommendation to refrain from noninvasive testing in low-risk patients.&lt;h4>Methods and results&lt;/h4>This was a pre- and postimplementation study with concurrent controls. Patients with chest pain were enrolled at 5 Swedish emergency departments (EDs) during a 10-month period in both 2017 and 2018. All hospitals used a 0h/3h hs-cTnT protocol in 2017 and 3 EDs implemented a 0h/1h hs-cTnT protocol during 10 months in 2018. The 2 coprimary outcomes were the incidence of acute myocardial infarction and all-cause death wi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-06-01T19:10:10.986Z</modification><creation>2025-07-10T03:08:26.815Z</creation></dates><accession>S-EPMC11935679</accession><cross_references><pubmed>39470043</pubmed><doi>10.1161/JAHA.124.036307</doi></cross_references></HashMap>